| Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 16 |
| Opened positions | 13 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 113.25 mm |
| Total shares | 5.76 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Baharaff Allen | 3.42 mm | $0.00 |
| Biotechnology Value Fund L P | 1.74 mm | $0.00 |
| Walleye Capital | 290.60 k | $83.11 mm |
| CVI Investments | 207.57 k | $301.00 k |
| CVI | 47.24 k | $13.51 mm |
| MS Morgan Stanley | 36.21 k | $9.96 mm |
| Susquehanna International | 11.63 k | $3.33 mm |
| Two Sigma Securities | 10.33 k | $2.84 mm |
| UBS UBS | 280.00 | $77.00 k |
| WFC Wells Fargo & Company | 204.00 | $56.00 k |
